Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 3.26 Delayed Data As of 3:59pm ET |  -0.16 / -4.68%Today’s Change | 1.77 Today|||52-Week Range 14.79 | -64.41% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $126.5M |
Company Description
Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Contact Information
Verrica Pharmaceuticals, Inc. 44 West Gay Street West Chester Pennsylvania 19380 |
Employees
Shareholders
| Individual stakeholders | 60.36% |
| Other institutional | 23.93% |
| Mutual fund holders | 11.67% |
Top Executives
| Ted White | President, Chief Executive Officer & Director |
| Terry Kohler | Chief Financial & Accounting Officer |
| Gary Goldenberg | Chief Medical Officer |
| Eugene Scavola | Executive Vice President-Technical Operations |
| Christopher G. Hayes | Secretary, Chief Legal & Compliance Officer |
